ORTH ANDREW C. 4
4 · Krystal Biotech, Inc. · Filed Mar 1, 2022
Insider Transaction Report
Form 4
ORTH ANDREW C.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+50,000→ 50,000 totalExercise: $63.55Exp: 2032-02-28→ Common Stock (50,000 underlying)
Holdings
- 100
Common Stock
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 28, 2023.